Immunogenic compositions for Streptococcus agalactiae
    11.
    发明授权
    Immunogenic compositions for Streptococcus agalactiae 有权
    无乳链球菌的免疫原性组合物

    公开(公告)号:US08945589B2

    公开(公告)日:2015-02-03

    申请号:US10568422

    申请日:2004-09-15

    CPC分类号: A61K39/09 Y10S530/825

    摘要: This application relates to Group B Streptococcus (“GBS”) vaccines comprising combinations of GBS polypeptide antigens where the polypeptides contribute to the immunological response in a recipient. Preferably, the compositions of the invention comprise a combination of two or more GBS antigens, wherein said combination includes GBS 80 or a fragment thereof. In one embodiment, the combination may consist of two to thirteen GBS antigens selected from an antigen group consisting of GBS 80, GBS 91, GBS 104, GBS 184, GBS 276, GBS 305, GBS 322, GBS 330, GBS 338, GBS 361, GBS 404, GBS 690, and GBS 691.

    摘要翻译: 本申请涉及包含GBS多肽抗原组合的B组链球菌(“GBS”)疫苗,其中多肽有助于接受者的免疫应答。 优选地,本发明的组合物包含两种或更多种GBS抗原的组合,其中所述组合包括GBS 80或其片段。 在一个实施方案中,该组合可以由选自GBS 80,GBS 91,GBS 104,GBS 184,GBS 276,GBS 305,GBS 322,GBS 330,GBS 338,GBS 361的抗原组中的两至十三个GBS抗原组成 ,GBS 404,GBS 690和GBS 691。

    Immunogenic Compositions for Streptococcus agalactiae
    12.
    发明申请
    Immunogenic Compositions for Streptococcus agalactiae 审中-公开
    无乳链球菌的免疫原性组合物

    公开(公告)号:US20120141521A1

    公开(公告)日:2012-06-07

    申请号:US13339628

    申请日:2011-12-29

    摘要: The invention relates to immunogenic polypeptides derived from epitopes in a Streptococcus agalactiae (“GBS”) protein GBS 80 and their use as prophylactic, diagnostic and therapeutic compositions. The invention also provides nucleic acids encoding the immunogenic polypeptides. Also provided are vectors useful for making such immunogenic polypeptides and host cells transformed with such vectors. In particular, the invention relates to a group immunogenic polypeptides derived from GBS 80. The compositions may include one or more of the immunogenic polypeptides either alone or with other antigenic components. For example, the immunogenic polypeptides may be combined with other GBS antigens to provide therapeutic compositions with broader range. In addition, the immunogenic polypeptides may also include flanking portions of the GBS 80 protein

    摘要翻译: 本发明涉及源自无乳链球菌(GBS)蛋白GBS 80中的表位的免疫原性多肽及其作为预防,诊断和治疗组合物的用途。 本发明还提供编码免疫原性多肽的核酸。 还提供了可用于制备这种免疫原性多肽的载体和用这些载体转化的宿主细胞。 特别地,本发明涉及衍生自GBS80的组免疫原性多肽。组合物可以单独或与其它抗原成分一起包括一种或多种免疫原性多肽。 例如,免疫原性多肽可以与其他GBS抗原组合以提供更宽范围的治疗组合物。 此外,免疫原性多肽还可以包括GBS 80蛋白的侧翼部分

    IMMUNOGENIC COMPOSITIONS
    13.
    发明申请
    IMMUNOGENIC COMPOSITIONS 审中-公开
    免疫组化

    公开(公告)号:US20130273091A1

    公开(公告)日:2013-10-17

    申请号:US13824041

    申请日:2011-09-16

    IPC分类号: A61K39/385

    摘要: The invention provides an immunogenic composition comprising: a) a conjugate that is a capsular saccharide from GBS serotype 1a conjugated to a carrier protein; b) a conjugate that is a capsular saccharide from GBS serotype 1b conjugated to a carrier protein; and c) a conjugate that is a capsular saccharide from GBS serotype III conjugated to a carrier protein. The invention also provides a method for immunising a patient against infection by GBS comprising the step of administering to the patient a conjugate that is a capsular saccharide from GBS conjugated to a diphtheria toxoid or derivative thereof, wherein the patient has been pre-immunised with a diphtheria toxoid or derivative thereof.

    摘要翻译: 本发明提供免疫原性组合物,其包含:a)缀合物,其是与载体蛋白缀合的GBS血清型1a的荚膜糖; b)缀合物,其是与载体蛋白质缀合的GBS血清型1b的荚膜糖; 和c)缀合物,其是与载体蛋白质缀合的GBS血清型III的荚膜糖。 本发明还提供了一种用于免疫患者免受GBS感染的方法,包括向患者施用作为与白喉类毒素或其衍生物缀合的GBS的荚膜糖的缀合物的步骤,其中所述患者已经用 白喉类毒素或其衍生物。